Ranpak Holdings Corp Class A (PACK)
Live price chart, market sentiment, and community perspectives for Ranpak Holdings Corp Class A (NYSE: PACK).
Live price chart, market sentiment, and community perspectives for Ranpak Holdings Corp Class A (NYSE: PACK).
On our desk, we are looking closely at PACK's valuation around the $5.23 level given a market cap of $441 million. With 9 analysts mapping a $7 price target, the upside case rests on steady execution of their razor-and-blade consumable model across over 144,000 installed systems, but near-term sentiment remains cautious due to ongoing net losses.
Watching the 52-week range of $3 to $8, PACK's debt-to-equity ratio of 0.7 and negative trailing EPS of -$0.45 require close monitoring. While Q1 2026 revenue increased 11.0% year-over-year to $101.2 million, the persistent net loss of $10.2 million highlights that operating leverage has not yet translated into positive bottom-line earnings.
In our quantitative framework, assessing Ranpak requires breaking down their geographic split—roughly 47% North America, 45% Europe, and 8% Asia and other regions. The business model relies heavily on recurring revenue from void-fill (45%), cushioning (36%), wrapping (9%), and automation solutions (10%), which provides good baseline visibility despite macro currency fluctuations.
As a hedge fund portfolio manager, I note that Adjusted EBITDA for the first quarter reached $18.9 million, up 9.2% year-over-year. However, flat performance on a constant currency basis indicates that foreign exchange tailwinds played a role in reported top-line expansion, a factor we must discount when projecting full-year cash flows.
When analyzing the technical setup ahead of the upcoming earnings reports slated for later in 2026, keep an eye on Protective Packaging Solutions system placements. With machine placement up only 0.2% year-over-year to 144.1 thousand at March 31, 2026, growth is driven primarily by consumable utilization and pricing rather than massive unit expansion.
Explore plasma cleansing, somatic organ swaps, and BCI.